508 related articles for article (PubMed ID: 21538941)
1. Overcoming in vivo barriers to targeted nanodelivery.
Chrastina A; Massey KA; Schnitzer JE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
Shokeen M; Fettig NM; Rossin R
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
[TBL] [Abstract][Full Text] [Related]
3. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticulate delivery systems for antiviral drugs.
Lembo D; Cavalli R
Antivir Chem Chemother; 2010; 21(2):53-70. PubMed ID: 21107015
[TBL] [Abstract][Full Text] [Related]
5. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle formulations in pulmonary drug delivery.
Bailey MM; Berkland CJ
Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
8. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
Danhier F; Feron O; Préat V
J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
[TBL] [Abstract][Full Text] [Related]
9. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
10. Challenges to macromolecular drug delivery.
Juliano R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
[TBL] [Abstract][Full Text] [Related]
11. Anticancer drug delivery with nanoparticles.
Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
[TBL] [Abstract][Full Text] [Related]
12. Current status of nanotechnology approaches for cardiovascular disease: a personal perspective.
Buxton DB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):149-55. PubMed ID: 20049786
[TBL] [Abstract][Full Text] [Related]
13. Unique benefits of nanotechnology to drug delivery and diagnostics.
McNeil SE
Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
15. Applications of nanoparticles in ophthalmology.
Diebold Y; Calonge M
Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. A perspective of nanotechnology in hypersensitivity reactions including drug allergy.
Montañez MI; Ruiz-Sanchez AJ; Perez-Inestrosa E
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):297-302. PubMed ID: 20485158
[TBL] [Abstract][Full Text] [Related]
18. Active targeting of brain tumors using nanocarriers.
Béduneau A; Saulnier P; Benoit JP
Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
[TBL] [Abstract][Full Text] [Related]
19. Transendothelial movement and caveolae.
Anderson RG
Nat Biotechnol; 2008 Apr; 26(4):380-1; author reply 381-2. PubMed ID: 18392012
[No Abstract] [Full Text] [Related]
20. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]